The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models
Fridkis-Hareli, Masha, Storek, Michael, Or, Eran, Altman, Richard, Katti, Suresh, Sun, Fang, Peng, Tao, Hunter, Jeff, Johnson, Krista, Wang, Yi, Lundberg, Ante S., Mehta, Gaurav, Banda, Nirmal K., MicVolume:
105
Langue:
english
Journal:
Molecular Immunology
DOI:
10.1016/j.molimm.2018.09.013
Date:
January, 2019
Fichier:
PDF, 3.30 MB
english, 2019
File converter
Plus de résultats de recherche
More benefits 
